Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Rectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Adenocarcinoma Of Esophagus 2Melanoma 1Laryngeal Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Clinical Stage III Gastric Cancer AJCC v8 1Carcinoma, Non-Small-Cell Lung 1Barrett Esophagus 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

Cisplatin 130Cetuximab 79Radiotherapy 76Docetaxel 58Carboplatin 46pembrolizumab 45Paclitaxel 44Fluorouracil 42Radiotherapy, Intensity-Modulated 35Drug Therapy 17Radiation 14Nivolumab 14Gefitinib 14Gemcitabine 13Surgical Procedures, Operative 12Oxaliplatin 11Erlotinib Hydrochloride 11Pemetrexed 10Celecoxib 10Capecitabine 10Bevacizumab 10130-nm albumin-bound paclitaxel 10tislelizumab 9Filgrastim 9Amifostine 9Albumin-Bound Paclitaxel 9durvalumab 7atezolizumab 7Chemoradiotherapy 7toripalimab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Head and Neck Neoplasms × Endoscopy × Clear all
NCT00334997 2013-12-19

Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis

National Cancer Institute (NCI)

Phase 2 Completed
50 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡